Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

Fortitech kicks off World Initiative for Nutrition

This article was originally published in The Tan Sheet

  • News

Executive Summary

Custom nutrient premix firm Fortitech launches the World Initiative for Nutrition, to combat global malnutrition in the form of vitamin and mineral deficiencies, the firm says in a Nov. 4 press release. The Schenectady, N.Y.-based company says the initiative "will work with governmental and non-governmental organizations, ingredient suppliers, local food mills and manufacturers to develop and deliver" safe and effective nutritional solutions. Françoise Chomé heads the initiative and brings experience working for the Global Alliance for Improved Nutrition Foundation

Custom nutrient premix firm Fortitech launches the World Initiative for Nutrition, to combat global malnutrition in the form of vitamin and mineral deficiencies, the firm says in a Nov. 4 press release. The Schenectady, N.Y.-based company says the initiative "will work with governmental and non-governmental organizations, ingredient suppliers, local food mills and manufacturers to develop and deliver" safe and effective nutritional solutions. Françoise Chomé heads the initiative and brings experience working for the Global Alliance for Improved Nutrition Foundation.
Table

View full table

Topics

Tags:
OTC Drugs
Latest Headlines

Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says

The Aspirin Test For AI?

Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire

Rx Advertising: Interchangeability Doesn’t Mean Clinical Superiority To Other Biosimilars, FDA Says

See All
UsernamePublicRestriction

Register

PS102283

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By